327 related articles for article (PubMed ID: 23733447)
1. HIV-associated neurocognitive disorders: perspective on management strategies.
Nabha L; Duong L; Timpone J
Drugs; 2013 Jun; 73(9):893-905. PubMed ID: 23733447
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated neurological disorders: a guide to pharmacotherapy.
Tan IL; McArthur JC
CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
[TBL] [Abstract][Full Text] [Related]
3. The far-reaching HAND of cART: cART effects on astrocytes.
Gonzalez H; Podany A; Al-Harthi L; Wallace J
J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
[TBL] [Abstract][Full Text] [Related]
4. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
Chan P; Brew BJ
Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
[TBL] [Abstract][Full Text] [Related]
5. CSF penetration by antiretroviral drugs.
Eisfeld C; Reichelt D; Evers S; Husstedt I
CNS Drugs; 2013 Jan; 27(1):31-55. PubMed ID: 23160938
[TBL] [Abstract][Full Text] [Related]
6. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
Bogoch II; Davis BT; Venna N
J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated neurocognitive disorders (HAND).
Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of HIV-associated neurocognitive disorders pathogenesis.
Gannon P; Khan MZ; Kolson DL
Curr Opin Neurol; 2011 Jun; 24(3):275-83. PubMed ID: 21467932
[TBL] [Abstract][Full Text] [Related]
9. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
Sharma I
HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558
[TBL] [Abstract][Full Text] [Related]
10. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.
Peluso MJ; Spudich S
Curr HIV/AIDS Rep; 2014 Sep; 11(3):353-62. PubMed ID: 25063356
[TBL] [Abstract][Full Text] [Related]
11. Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.
Rappaport J; Volsky DJ
J Neurovirol; 2015 Jun; 21(3):235-41. PubMed ID: 25933548
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?
Brew BJ; Clifford DB
AIDS; 2023 Nov; 37(13):2095-2096. PubMed ID: 37755427
[No Abstract] [Full Text] [Related]
13. Therapy recommendations for HIV-associated neurocognitive disorders.
Zirulnik JL
JAMA; 2008 Dec; 300(21):2482; author reply 2482-3. PubMed ID: 19050186
[No Abstract] [Full Text] [Related]
14. Neurocognitive impairment and neuroCART.
Wright E
Curr Opin HIV AIDS; 2011 Jul; 6(4):303-8. PubMed ID: 21546833
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.
Gill AJ; Kolson DL
Curr HIV/AIDS Rep; 2014 Sep; 11(3):325-35. PubMed ID: 24929842
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of HIV in the central nervous system.
Valcour V; Sithinamsuwan P; Letendre S; Ances B
Curr HIV/AIDS Rep; 2011 Mar; 8(1):54-61. PubMed ID: 21191673
[TBL] [Abstract][Full Text] [Related]
17. HIV encephalitis in a patient on antiretroviral therapy: a case report.
Hlebowicz M; Parczewski M; Jakubowski P
Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.
Cysique LA; Brew BJ
Neuropsychol Rev; 2009 Jun; 19(2):169-85. PubMed ID: 19424802
[TBL] [Abstract][Full Text] [Related]
19. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.
Taiwo B; Hicks C; Eron J
J Antimicrob Chemother; 2010 Jun; 65(6):1100-7. PubMed ID: 20348088
[TBL] [Abstract][Full Text] [Related]
20. HIV pharmacology: barriers to the eradication of HIV from the CNS.
McGee B; Smith N; Aweeka F
HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
